Antonio Passaro recognized among the top 2% of scientists by Stanford University

Antonio Passaro shared the following on LinkedIn:

“Exciting News!

I am proud to share that I have once again been recognized among the top 2% of scientists worldwide in the latest ranking released by Stanford University. I am thrilled to share this recognition with Prof. Lorenzo Spaggiari (Director of the Lung Program & Division of Thoracic Surgery at IEO) and Prof Filippo de Marinis (Director of Division of Thoracic Oncology).

This accolade is not just a personal achievement; it reflects the hard work and dedication of our entire team at IEO Istituto Europeo di Oncologia. I want to extend my heartfelt gratitude to all my colleagues who tirelessly contribute to the study, research, and treatment of lung cancer every single day in our Institute. Together, we are making a difference!

Check out the full list here: [Stanford University Top 2% Scientists].”

Source: Antonio Passaro/LinkedIn

More posts featuring Antonio Passaro on oncodaily.com

Antonio Passaro MD PhD, a medical oncologist at the European Institute of Oncology in Milan, specializes in lung cancer research and treatment. He focuses on developing new therapies, including immunotherapy, and identifying reliable biomarkers for non-small cell lung cancer (NSCLC).

Dr. Antonio Passaro is an Associate Editor for Lung Cancer Journal by Elsevier and the Chair of the ESMO Press & Media Affairs Committee.

He is also a faculty member for the Lung and Other Thoracic Tumours faculty group and the ESMO-MCBS Extended Working Group. He also holds editorial positions and key roles in societies like ESMO and AIOM.